ThinkSono, founded in 2016, is revolutionizing the healthcare industry by leveraging artificial intelligence to democratize access to ultrasound diagnostics. Their slogan, "Building the future of ultrasound with artificial intelligence.", encapsulates their mission to remove barriers to universal ultrasound accessibility.
The company's flagship application, ThinkSono Guidance, empowers healthcare professionals to diagnose deep vein thrombosis (DVT) swiftly, offering the potential for detection in as little as five minutes. This capability is a significant advancement, particularly in the context of point-of-care diagnostics.
Operating at the intersection of AI, Health Care, and IT, ThinkSono is headquartered in the United Kingdom. They recently secured a £2.10M Seed Round investment (March 2024) from investors including BC Brandenburg Capital, Dubai Angel Investors - DAI, Crowdcube, Cur8 Capital, Calm/Storm, and Id4 ventures. This investment underscores strong institutional belief in their innovative approach to healthcare solutions.